|
OSGEPL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.398930E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.819900E-04 |
| Normal-vs-Stage2 |
2.698700E-03 |
| Normal-vs-Stage3 |
1.283010E-03 |
| Normal-vs-Stage4 |
1.965830E-02 |
| Stage1-vs-Stage2 |
6.848000E-01 |
| Stage1-vs-Stage3 |
9.191000E-01 |
| Stage1-vs-Stage4 |
7.015600E-01 |
| Stage2-vs-Stage3 |
7.775800E-01 |
| Stage2-vs-Stage4 |
5.744400E-01 |
| Stage3-vs-Stage4 |
7.001200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.647790E-04 |
| Normal-vs-AfricanAmerican |
4.722400E-02 |
| Normal-vs-Asian |
3.409000E-01 |
| Caucasian-vs-AfricanAmerican |
7.699400E-01 |
| Caucasian-vs-Asian |
2.122100E-02 |
| AfricanAmerican-vs-Asian |
2.509600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.221900E-03 |
| Normal-vs-Female |
1.164150E-04 |
| Male-vs-Female |
7.701800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.583300E-04 |
| Normal-vs-Age(41-60Yrs) |
4.433000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.631750E-02 |
| Normal-vs-Age(81-100Yrs) |
1.256450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.422600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.720200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.436400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.933400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.116800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.018200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.444200E-01 |
| Classical-VS-Follicular |
5.516500E-02 |
| Classical-VS-Other |
4.562200E-01 |
| Classical-VS-Normal |
1.217240E-03 |
| Tall-VS-Follicular |
2.273600E-01 |
| Tall-VS-Other |
5.941200E-01 |
| Tall-VS-Normal |
6.228400E-02 |
| Follicular-VS-Other |
2.258800E-01 |
| Follicular-VS-Normal |
2.025100E-04 |
| Other-VS-Normal |
6.046400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.431900E-04 |
| Normal-vs-N1 |
7.185800E-02 |
| N0-vs-N1 |
2.933200E-01 |
|
|
